Artelo Biosciences Retains Crescendo Communications, LLC for Investor Relations Services
Clinical-Stage Biopharmaceutical Company Engages Financial Industry Veteran LA JOLLA, CA / ACCESSWIRE / May 8, 2019 / Artelo Biosciences, Inc....
user
Top Rated Chiropractor Moves To New And Improved Location In New York, NY
NEW YORK, NY / ACCESSWIRE / May 8, 2019 / Better Health Chiropractic PC is pleased to announce that they...
Medical Technology Playing Vital Role in Early Detection of Heart Attacks Among Younger Women
By Stuart Long, CEO of InfoBionic Improvements in data storage and management, deep learning, artificial intelligence and secure telecommunications have...
Altus Formulation Partners with Evonik to Manufacture its Proprietary SmartCelle Insoluble Drug Delivery Technology
MONTREAL, QC / ACCESSWIRE / May 8, 2019 / SmartCelleTM is Altus Formulation's proprietary polymeric micellar technology for parenteral, oral...
BridgeHead Software appoints David Moysen as Director of IT
Proven IT specialist will oversee global IT infrastructure roadmap and drive organisational performanceASHTEAD, UK – 8 May 2019 – BridgeHead...
EVITRADE Announces Rebranding and Name Change to THERAMED Health Corporation
VANCOUVER, BC / ACCESSWIRE / Tuesday, May 7, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the 'Company')...
Intellipharmaceutics Closes US$1.05 Million Convertible Debenture Financing with Drs. Isa and Amina Odidi
TORONTO, ON / ACCESSWIRE / May 7, 2019 / Intellipharmaceutics International Inc. (OTCQB: IPCIF and TSX: IPCI) ("Intellipharmaceutics" or the...
MorphoSys AG Reports First Quarter 2019 Results
Conference call and webcast (in English) to be held on May 8, 2019 at 2:00pm CEST (1:00pm BST/8:00am EDT) -...
Calidi Biotherapeutics Granted Patent for Cell-Based Oncolytic Virus Immunotherapy for Cancer Treatment
SAN DIEGO, CA / ACCESSWIRE / May 7, 2019 / Calidi Biotherapeutics, Inc. is happy to announce the United States...
Dr. Jan McBarron Offers Support to Individuals Pursuing a Post-Secondary Education in Health-Related Studies
Established doctor and philanthropist Jan McBarron is committed to ensuring that deserving students in the field of health and medicine...
EAMSP kicks off information campaign about digitization in German healthcare sector
Fighting the allergic reaction to anything new with #neuschnupfenBrussels, Belgium | Hamburg, Germany, May 7, 2019. While online banking, ordering...
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / May 7, 2019 / Utah Medical Products, Inc. (NASDAQ: UTMD) announces that its...
Arcutis, Inc.’s ARQ-151 Development Program for Plaque Psoriasis
ARQ-151 Potential "Best in Class" Topical PDE4 inhibitor ARQ-151 Potentially Only Topical PDE4 inhibitor for Psoriasis Phase 2a Study in...
International Cannabrands Announces Distribution Deal with Nabis
DENVER, CO / ACCESSWIRE / May 7, 2019 / International Cannabrands Inc. (CSE: JUJU) (the 'Company') is pleased to announce...
Adial Pharmaceuticals Announces Collaboration Agreement with Eurofins for Genetic Biomarker Testing to Support Upcoming Phase 3 Clinical Trial for Alcohol Use Disorder
CHARLOTTESVILLE, VA / ACCESSWIRE / May 7, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) www.adialpharma.com, a clinical-stage biopharmaceutical company...
DECN’s Appeal Nearing Oral Arguments in its Patent Battle with Johnson & Johnson Over the Unjust Ruling in the Nevada Lower Court
Appeals Court Set to Hear and Then Decide DECN's Seminal Legal Question at Issue in Long Simmering Patent Battle with...
Evotec SE to Report First Quarter 2019 Results on 14 May 2019
HAMBURG, GERMANY / ACCESSWIRE / May 7, 2019 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) will report...
VistaGen Therapeutics to Present at ChinaBio(R) Partnering Forum in Shanghai, China
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / May 7, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing...
Aytu BioScience to Report Fiscal Third Quarter 2019 Results and Business Update
Live Conference Call and Webcast Scheduled for May 14, 2019, at 9:00 a.m. ET ENGLEWOOD, CO / ACCESSWIRE / May...
Preferred Dental Technologies Inc. (”Company”) (CSE: PDTI, US OTC: PDTTF): PDTI Receives 3D Patent Grant from US Patent and Trademark Office
WINNIPEG, MB / ACCESSWIRE / May 7, 2019 / Preferred Dental Technologies Inc. (PDTI) has been granted an additional patent...